Search for: "Harvard Drug Company, LLC"
Results 21 - 31
of 31
Sort by Relevance
|
Sort by Date
10 Feb 2010, 4:47 pm
Xenotech, LLC et al. [read post]
28 Nov 2009, 4:23 pm
A drug company is pursuing MJ research; CAM is urged as part of health reform.I have helped at least one California client with a medical marijuana (MMJ) project. [read post]
9 Nov 2009, 6:01 am
Those findings were reported in an October 2005 article in the Journal of the American Medical Association. 'Don't Respect the Law' "Marketing departments of many drug companies don't respect any boundaries of professionalism or the law," says Jerry Avorn, a professor at Harvard Medical School in Boston and author of "Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs" (Random House, 2004). [read post]
26 Sep 2009, 8:45 pm
Other companies such as 3M and Gore have similar strategies. [read post]
27 Feb 2009, 5:00 am
(Patent Docs) (Afro-IP) Access to drugs: Gilead’s non exclusive model (Afro-IP) (GenericsWeb) India: Drug patent linkage is subject of court case, dispute in India (Intellectual Property Watch) India: Ranbaxy’s manufacturing woes deepen; USFDA invokes Application Integrity Policy against Paonta Sahib facility (FDA Law Blog) UK patent practice on human embryos post-WARF (IPKat) US: Congressman Waxman tells GPhA meeting that Hatch-Waxman model will work for… [read post]
11 Jul 2008, 4:30 am
: (IAM), (Patent Circle), India takes open source approach to drug discovery: (Patent Lens), India: Indian Bayh Dole Bill: (Spicy IP), (Spicy IP), (Does India need Bayh-Dole? [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade… [read post]
18 Apr 2008, 2:00 am
: (Spicy IP), India: OPPI recommends timeframe for pre-grant opposition: (Spicy IP), India: Jatropha patents (agri-biotech): (Spicy IP), India & US: Stem cell patents: (Spicy IP), Kenya: GSK presses Kenya to crack down on imports of fake medicines: (Afro-IP), Nigeria: Interview with Director General of NAFDAC - Cracking down on counterfeit drugs: (Afro-IP), EU: No link between parallel trade and reduction in R&D, says AG in Sot. [read post]
11 Apr 2008, 9:00 am
Forest Laboratories, Inc. turns law of declaratory judgment on its head: (Patent Docs), (Patent Baristas), Mircera (Methoxy polyethylene glycol-epoetin beta) – Roche appeals preliminary injunction barring US sales of Mircera in patent infringement battle with Amgen: (Philip Brooks), (IP Law360), Norvasc (Amlodipine) – Ranbaxy becomes first foreign generic company to develop a generic product independently outside Japan and receive authorization from MHLW-Japan:… [read post]
22 Feb 2008, 2:30 am
[www.erikjheels.com]Et Seq.The Harvard Law School Library Blog[etseq.law.harvard.edu]HealthBlawgNew developments in health care law and policy together with the observations and analysis of David Harlow, of The Harlow Group LLC, a health care law and consulting firm in Newton.http://healthblawg.typepad.com/healthblawg/Home Contractor vs. [read post]
15 Feb 2008, 9:00 am
: (IPBiz),Eco-patent commons meets open innovation: (Securing Innovation),Settle the patent infringement case by selling your company? [read post]
